home / stock / jmacw / jmacw quote
Last: | $0.12 |
---|---|
Change Percent: | -2.3% |
Open: | $0.1024 |
Close: | $0.12 |
High: | $0.12 |
Low: | $0.1011 |
Volume: | 124,606 |
Last Trade Date Time: | 03/29/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.12 | $0.1024 | $0.12 | $0.12 | $0.1011 | 124,606 | 03-29-2023 |
$0.1001 | $0.11 | $0.1001 | $0.112 | $0.1 | 47,253 | 03-28-2023 |
$0.1118 | $0.095 | $0.1118 | $0.1175 | $0.09 | 74,547 | 03-27-2023 |
$0.1 | $0.12 | $0.1 | $0.12 | $0.1 | 57,771 | 03-24-2023 |
$0.1 | $0.11 | $0.1 | $0.1275 | $0.0904 | 114,513 | 03-23-2023 |
$0.11 | $0.12 | $0.11 | $0.16 | $0.11 | 504,966 | 03-22-2023 |
$0.1081 | $0.105 | $0.1081 | $0.115 | $0.1 | 15,901 | 03-21-2023 |
$0.12375 | $0.11 | $0.12375 | $0.125 | $0.0975 | 95,523 | 03-20-2023 |
$0.1164 | $0.119 | $0.1164 | $0.135 | $0.0923 | 163,195 | 03-17-2023 |
$0.1187 | $0.125 | $0.1187 | $0.125 | $0.11 | 5,443 | 03-16-2023 |
$0.130667 | $0.135 | $0.130667 | $0.135 | $0.1225 | 6,504 | 03-15-2023 |
$0.1278 | $0.13 | $0.1278 | $0.13135 | $0.1277 | 1,957 | 03-14-2023 |
$0.12 | $0.12 | $0.12 | $0.12 | $0.12 | 5,970 | 03-13-2023 |
$0.12 | $0.12 | $0.12 | $0.1225 | $0.12 | 5,000 | 03-10-2023 |
$0.12 | $0.12 | $0.12 | $0.1299 | $0.12 | 21,800 | 03-09-2023 |
$0.12 | $0.12 | $0.12 | $0.122 | $0.1199 | 34,930 | 03-07-2023 |
$0.1179 | $0.120101 | $0.1179 | $0.121913 | $0.1179 | 29,820 | 03-06-2023 |
$0.1158 | $0.1 | $0.1158 | $0.120101 | $0.1 | 32,850 | 03-03-2023 |
$0.12 | $0.11 | $0.12 | $0.12 | $0.0975 | 13,870 | 03-02-2023 |
$0.1057 | $0.1 | $0.1057 | $0.113 | $0.1 | 13,450 | 03-01-2023 |
News, Short Squeeze, Breakout and More Instantly...
Maxpro Capital Acquisition Corp. Warrants Company Name:
JMACW Stock Symbol:
NASDAQ Market:
FOSTER CITY, Calif., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: JMAC), an innovative biopharmaceutical company committed to the discovery and development of mono- and combination-oncology therapies, today announced that the U.S. Food and Drug Administration (FDA) ha...
TAIPEI CITY, Oct. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) (the “Company”) announced today that its sponsor, MP One Investment LLC (the “Sponsor”), deposited an additional payment in the aggregate ...
Taipei City, Oct. 07, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) (the “Company”), announced today that its sponsor, MP One Investment LLC (the “Sponsor”), has requested that the Company extend the date by ...